| Literature DB >> 32270195 |
Gauthier Schang1, Luisina Ongaro1, Hailey Schultz2, Ying Wang1, Xiang Zhou1, Emilie Brûlé2, Ulrich Boehm3, Se-Jin Lee4,5, Daniel J Bernard1,2.
Abstract
Activins are selective regulators of FSH production by pituitary gonadotrope cells. In a gonadotrope-like cell line, LβT2, activins stimulate FSH via the activin type IIA receptor (ACVR2A) and/or bone morphogenetic protein type II receptor (BMPR2). Consistent with these observations, FSH is greatly reduced, though still present, in global Acvr2a knockout mice. In contrast, FSH production is unaltered in gonadotrope-specific Bmpr2 knockout mice. In light of these results, we questioned whether an additional type II receptor might mediate the actions of activins or related TGF-β ligands in gonadotropes. We focused on the activin type IIB receptor (ACVR2B), even though it does not mediate activin actions in LβT2 cells. Using a Cre-lox strategy, we ablated Acvr2a and/or Acvr2b in murine gonadotropes. The resulting conditional knockout (cKO) animals were compared with littermate controls. Acvr2a cKO (cKO-A) females were subfertile (~70% reduced litter size), cKO-A males were hypogonadal, and both sexes showed marked decreases in serum FSH levels compared with controls. Acvr2b cKO (cKO-B) females were subfertile (~20% reduced litter size), cKO-B males had a moderate decrease in testicular weight, but only males showed a significant decrease in serum FSH levels relative to controls. Simultaneous deletion of both Acvr2a and Acvr2b in gonadotropes led to profound hypogonadism and FSH deficiency in both sexes; females were acyclic and sterile. Collectively, these data demonstrate that ACVR2A and ACVR2B are the critical type II receptors through which activins or related TGF-β ligands induce FSH production in mice in vivo. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: ACVR2A; ACVR2B; FSH; LH; fertility; gonadotropes
Mesh:
Substances:
Year: 2020 PMID: 32270195 PMCID: PMC7286621 DOI: 10.1210/endocr/bqaa056
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736